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We investigated hypocholesterolemic mechanisms of linalool, an aromatic anti-oxidative monoter-
pene, which is abundant in teas and essential oils. Oral administration of linalool to mice for
6 weeks signiﬁcantly lowered total and low-density lipoprotein cholesterol concentrations, and
HMG-CoA reductase protein expression (46%; P < 0.05) by both transcriptional and posttranscrip-
tional mechanisms. Linalool suppressed the gene expression of HMG-CoA reductase by reducing
the binding of SREBP-2 to its promoter, as assessed by qPCR and chromatin immunoprecipitation,
and by inducing ubiquitin-dependent proteolysis of the HMG-CoA reductase. These ﬁndings suggest
that food molecules with a pleasant scent could exert beneﬁcial metabolic effects through multiple
mechanisms.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction results regarding green tea catechins in humans have not beenHypercholesterolemia is a key risk factor in atherosclerosis,
with the formation of atheromas after cholesterol buildup in the
coronary arteries, and the subsequent development of coronary
heart disease (CHD) [1]. In a meta-analysis, a 10 mg/dl reduction
in plasma cholesterol level was shown to decrease the CHDmortal-
ity by up to 9% [2]. This level of cholesterol decrease could be
achieved by a nutritionally balanced diet that included a low intake
of saturated fat and cholesterol and a high intake of ﬁber and phy-
tochemicals [3]. Phytochemicals from herbs and teas may reduce
plasma cholesterol levels, which may be important for preventing
CHD, especially in those with mild hypercholesterolemia and ele-
vated CHD risk [4].
The cholesterol-lowering activity of teas has been intensively
investigated [5]. Tea derived from the leaves of Camellia sinensis
is the world’s most popular and widely consumed beverage. Stud-
ies on the hypocholesterolemic effects of teas have focused partic-
ularly on green tea catechins as key active compounds [6], yet thechemical Societies. Published by E
aryl-coenzyme A reductase;
CHD, coronary heart disease;
tion; 25-HC, 25-hydroxycho-
responsive element; PCAF,
P, site-2 protease; LDL, low-consistent [7], although data from a meta-analysis have suggested
a signiﬁcant reduction in low-density lipoprotein (LDL) cholesterol
associated with green tea intake [8]. The possibility exists that
other compounds in teas may contribute to plasma cholesterol
reduction and that small aromatic anti-oxidative terpenes in teas
may be candidates. However, metabolic functions of tea terpenoids
have been largely ignored [9]. The small aromatic terpenes are also
present at high concentrations in herbal essential oils. Several re-
cent in vitro and in vivo metabolic studies on herbal essential oils
rich in small aromatic terpenoids have been shown to reduce plas-
ma cholesterol levels by downregulating 3-hydroxy-3-methylglut-
aryl-coenzyme A reductase (HMGCR) expression [10,11].
Linalool (MW, 154.25 g/mol) is a naturally occurring small ter-
pene with a pleasant scent and strong anti-oxidative activity
[12,13]. Linalool is a major or common compound in most herbal
essential oils and teas, including both green and black teas [14].
Linalool is characterized by a pleasant ﬂoral scent and is present
in more than 200 species of plants in families such as Lamiaceae
(mints, scented herbs), Lauraceae (laurels, cinnamon, rosewood),
and Rutaceae (citrus fruits). The strong antioxidant activity of lin-
alool inhibits LDL oxidation, which enhances cholesterol uptake via
macrophage scavenger receptors [12,13]. Therefore, this molecule
may exhibit in vivo anti-atherogenic activity.
In this study, we examined the hypocholesterolemic effects of
linalool in high-fat fed C57BL/6J mice and HepG2 cells. Linalool sig-
niﬁcantly decreased total and LDL cholesterol concentrations bylsevier B.V. All rights reserved.
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expression and a concomitant reduction in HMGCR expression
via the acceleration of ubiquitin-dependent degradation and
downregulation of its transcription.
2. Materials and methods
An expanded Materials and methods section, including chemi-
cals and reagents, plasma lipid determination, cellular lipid deter-
mination, isolation of total RNA and reverse-transcription PCR,
ubiquitination of HMGCR, chromatin immunoprecipitation (ChIP)
assay, and immunocytochemistry, is available in the Supplemen-
tary materials available online.
2.1. Animals
Male C57BL/6J mice (Samtako Korea, Gyeonggi-Do, Korea),
10–12 weeks old, were divided into three groups (6 mice per
group, 26–30 g body weight) and fed an AIN-76A-based high-fat
diet (HFD) containing 45% of the total calories from fats, 20% from
proteins, and 35% from carbohydrates for 5 weeks prior to linalool
administration. Then, the mice were continuously fed the same
HFD during the oral administration of linalool for an additional
6 weeks. Two doses were examined in the animal experiments:
low (0.57 mg/mouse/d) and high (120 mg/mouse/d) levels. Previ-
ously, we reported hypocholesterolemic effects of Plantago asiatica
essential oil, which contained 82% (v/w) linalool [11], and the low
concentration was extrapolated from the effective dose of P. asiat-
ica essential oil. The high concentration was determined as the
highest non-toxic concentration based on the data for cellular tox-
icity and LD50 [15,16]. The high concentration was reported as non-
toxic in mice and showed anti-inﬂammatory activity. At 0, 3, and
6 weeks, blood samples were collected retroorbitally into EDTA-
treated tubes from mice fasted overnight for 8–10 h. Plasma sam-
ples were obtained by centrifugation at 12000g for 15 min at 4 C
and stored at 20 C until analysis. The mice were killed after the
feeding period. The organs were snap-frozen in liquid nitrogen and
stored at 80 C for RNA and protein analyses. All animal proce-
dures were performed in accordance with a protocol approved by
the Animal Experimentation and Ethics Committee of Korea Uni-
versity (protocol No. KUIACUC-20090420-4).
2.2. Cell culture and linalool treatment
HepG2 cells were seeded in 6-well Falcon plates at 5  105 cells/
well in Dulbecco’smodiﬁed Eagle’smedium (DMEM) supplemented
with 10% fetal bovine serum (FBS) and 1% PEST (contains 100 units/
ml penicillin and100 lg/ml streptomycin in cell culture gradewater
for gram-positive and gram-negative bacteria). Cells were cultured
at 37 C in a humidiﬁed atmosphere containing 5% CO2 until they
were 60–80% conﬂuent before using them for RT-PCR, Western blot
analysis, ChIP assay, and immunocytochemistry. The culture med-
iumwas changed every 2 days, and the cellswere kept in serum-free
media during the treatment period. Linalool was dissolved in
dimethyl sulfoxide (DMSO) to the ﬁnal treatment concentrations.
Cells were exposed to 0, 0.1, and 0.5 mM linalool for 24 h.
2.3. RNA isolation and quantitative real-time PCR (qPCR)
Total RNA was extracted from HepG2 cells and mouse livers
using a TRIzol reagent kit (Invitrogen, Carlsbad, CA, USA), following
the manufacturer’s protocol. For cDNA synthesis, 2 lg of total RNA
was reverse-transcribed using Superscript II reverse transcriptase
(Invitrogen), according to the manufacturer’s protocol, and a
combination of oligo(dT)15 primers, resulting in 20 ll of cDNA.
PCR was performed using 1 U of Taq DNA polymerase (Promega,Madison, WI, USA) and 1 ll of cDNA template. The primers used
for PCR are listed in Supplementary Table 1. Real-time PCR was
performed in a reaction volume of 20 ll containing 10 ll of iQ
SYBR Green Supermix (Bio-Rad, Hercules, CA, USA), 1 ll of primers
(10 lM), 1 ll of cDNA, and sterile water. PCR conditions were 95 C
for 5 min, followed by 50 cycles of 95 C for 30 s, 57 C for 30 s, and
72 C for 30 s, with a ﬁnal extension at 72 C for 5 min. A melting
curve of the ampliﬁed DNA was analyzed at temperatures between
54 and 95 C at a heating rate of 0.2 C/s. Quantitative PCR was per-
formed in an iCycler iQ instrument (Bio-Rad). During primer exten-
sion, the ﬂuorescence from the ampliﬁed DNA was recorded using
the SYBR Green optic channel set at a wavelength of 490 nm. Data
were collected and viewed using iCycler iQ optical system software
version 5 (Bio-Rad).
2.4. Immunoblotting and nuclear and membrane protein isolation
Proteins were isolated from the nuclear and membrane frac-
tions using a kit (Cayman Chemical, Ann Arbor, MI, USA) according
to the manufacturer’s protocol. SDS–PAGE and immunoblotting
were performed as described previously [11]. A Bio-Rad Chemidoc
XRS system and software were used to capture chemiluminescent
images, and band intensities were determined using the Bio-Rad
Quantity One image analyzing program.
2.5. Data analysis
All experiments were repeated at least three times. Quantiﬁable
data are shown as means ± S.E.M. The signiﬁcance of differences
was evaluated using Student’s t test and the Tukey–Kramer multi-
ple-comparison post hoc test.
3. Results
3.1. Linalool has hypocholesterolemic effects
We investigated the lipid-lowering ability of linalool in mice.
Body weight and food intake were similar among groups during
the feeding period (Supplementary Fig. 1A and B). After 6 weeks
of oral administration, linalool signiﬁcantly reduced plasma TG,
total cholesterol, and LDL levels (Fig. 1A). In comparison with con-
trols, total cholesterol levels were reduced by 14% in both the low
(0.57 mg linalool/mouse/d) and high linalool groups (120 mg linal-
ool/mouse/d) at 6 weeks, and triglycerides were reduced markedly
by 40% and 31% at 3 and 6 weeks, respectively, in the low linalool
group. LDL cholesterol levels were also signiﬁcantly reduced by
45% and 42% at both 3 and 6 weeks, respectively, in the low linalool
group compared with controls. At 6 weeks, HDL cholesterol tended
to increase in both the low (+26%) and high (+14%) linalool groups.
Several atherogenic indexes showed that the plasma lipoprotein
proﬁles were improved after linalool administration (Table 1).
The livers of control mice fed the HFD showed lipid accumulation,
but this accumulation of lipids was markedly reduced in the livers
of mice fed linalool at both high and low concentrations, and the
overt, large lipid droplets had disappeared as assessed by immuno-
histochemistry after oil red O staining (data not shown). Hepatic li-
pid levels measured in HepG2 cells showed a dose-dependent
reduction of cellular cholesterol and TG concentrations by 34%
and 37%, respectively, at 1 mM linalool (Fig. 1B).
3.2. Linalool reduces SREBP-2 expression and attenuates nuclear
translocation
The expression of SREBP-2, a key transcription factor in cellular
cholesterol homeostasis, was quantiﬁed. Linalool-treated HepG2
cells showed a 66% (P < 0.01) reduction in the level of SREBP-2
Fig. 1. Hypolipidemic activities of linalool. (A) Plasma triglyceride (TG), total cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) concentrations
after linalool administration in mice. Control mice were fed the same volume of water. Low (0.57 mg/mouse/d) and high doses of linalool (120 mg/mouse/d) were orally
administered to mice daily for 6 weeks. (B) Cellular hepatic cholesterol and TG levels. A more detailed method is provided in the Supplementary methods. Data are presented
as means ± S.E.M. (n = 3 per group). ⁄P < 0.05 compared with control; ⁄⁄P < 0.01 compared with control.
Table 1
Effects of linalool on plasma atherogenic indices in high-fat diet-induced obese
C57BL/6J mice.
Atherogenic index Week 0 Week 3 Week 6
LDL-C/HDL-C
Control 0.65 ± 0.05 0.65 ± 0.02 0.58 ± 0.01
Low 0.57 ± 0.04 0.29 ± 0.04** 0.27 ± 0.03**
High 0.49 ± 0.02 0.23 ± 0.07** 0.23 ± 0.06**
TG/HDL-C
Control 1.06 ± 0.01 0.89 ± 0.02 0.92 ± 0.02
Low 1.37 ± 0.01 0.72 ± 0.06** 0.63 ± 0.03**
High 1.36 ± 0.01 0.74 ± 0.07** 0.80 ± 0.05*
TC/HDL-C
Control 2.06 ± 0.02 1.93 ± 0.02 2.00 ± 0.02
Low 2.06 ± 0.02 1.60 ± 0.02** 1.47 ± 0.01**
High 1.82 ± 0.02 1.46 ± 0.01** 1.34 ± 0.01**
* P < 0.05.
** P < 0.01.
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concentration signiﬁcantly decreased SREBP-2 mRNA expression
by 60% (P < 0.01) as well. In HepG2 cells analyzed by immunoblot-
ting, the precursor form of SREBP-2 (pSREBP) decreased by 37% and
49% at 0.1 and 0.5 mM, respectively. The nuclear form of SREBP-2
(nSREBP) was reduced by 35% and 65% at 0.1 and 0.5 mM linalool,respectively (Fig. 2A). In mouse livers, the low linalool concentra-
tion reduced the expression of the nuclear and precursor forms
of SREBP-2 by 68% and 55%, respectively. In HepG2 cells, the nucle-
ar-to-precursor ratio of SREBP-2 protein was lowered by 32% at
0.5 mM linalool compared with controls. A similar trend was found
in mouse livers since decreases of almost 30% were observed for
both concentration of linalool.
We further investigated SREBP-2 expression in HepG2 cells by
immunohistochemistry and confocal microscopy. In controls,
SREBP-2 protein was highly expressed and evenly localized in both
the cytoplasm and nucleus (Fig. 2B); however, after treatment with
0.1 mM or 0.5 mM linalool, SREBP-2 protein levels were markedly
reduced in the cells, especially in cells incubated with 0.5 mM
linalool. Confocal images were examined to quantify the distribu-
tion and prevalence of the SREBP-2 protein. After normalization,
linalool-treated cells (0.5 mM) showed reductions in the SREBP-2
protein by 50% and 65% for the precursor and mature form, respec-
tively, compared with controls, conﬁrming a reduction in SREBP-2
protein with linalool treatment (P < 0.01; Fig. 2C). In addition, the
nuclear-to-precursor ratio of SREBP-2 protein was also decreased
by 30% at 0.5 mM linalool compared with controls, which was sim-
ilar to the result obtained from immunoblotting analysis. These
observations suggest that linalool reduced the gene expression of
SREBP-2 and attenuated posttranscriptional nuclear translocation
of SREBP-2.
Fig. 2. Expression of SREBP-2. HepG2 cells and mouse livers after linalool treatment as described in Section 2. (A) SREBP-2 mRNA and protein expression. (B) Cellular
localization of SREBP-2. The immunohistochemistry procedure is provided in the Supplementary methods. Images (1000) were obtained by confocal microscopy. The
cellular distribution and expression of SREBP-2 protein (Alexa 488, green) with respect to the nucleus (DAPI, blue) and b-tubulin (Alexa 555, red) as a housekeeping gene
(red). (C) SREBP-2 protein expression was quantiﬁed by image analysis. MetaMorph 7.6 (Molecular Devices, Sunnyvale, CA, USA) was used for image analysis. Data are
presented as means ± S.E.M. (n = 3 per group). ⁄P < 0.05 compared with control; ⁄⁄P < 0.01 compared with control.
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In both HepG2 cells and mouse livers, the levels of HMGCR
mRNA expression, as determined by both RT-PCR and qRT-PCR,were reduced signiﬁcantly (up to 45%) with 0.5 mM linalool
(Fig. 3A). HMGCR protein expression decreased by 54% with
0.5 mM linalool in vitro. Low and high concentrations of linalool
reduced HMGCR mRNA expression by 66% and 79%, respectively
S.-Y. Cho et al. / FEBS Letters 585 (2011) 3289–3296 3293(P < 0.05) in mice as assessed by qRT-PCR. Protein levels were re-
duced by 54% (P < 0.01) at 0.5 mM linalool in vitro and 55%
(P < 0.05) in the low linalool group compared with controls
(Fig. 3A). No signiﬁcant changes were found in LDL receptor or
CYP7A1 mRNA expression in vitro or in vivo (Supplementary
Fig. 2).
HMGCR protein is degraded by Insig-dependent ubiquitination,
and oxysterols such as 25-hydroxycholesterol (25-HC) stimulateFig. 3. Expression of HMGCR and Insig-dependent ubiquitination of HMGCR. HepG2 ce
ubiquitination method is provided in the Supplementary methods. (A) HMGCR mR
ubiquitination of HMGCR. Cells were treated with 0.1 mM or 0.5 mM linalool, or a mixture
The cells were harvested and subjected to immunoprecipitation with anti-HMGCR IgG a
were subjected to 10% SDS–PAGE, followed by immunoblotting analysis with a polycl
visualized by ECL with an exposure time of 3–5 min.the process [17]. The expression of Insig-1 was upregulated with
linalool treatment and feeding (Fig. 3B); thus we further investi-
gated whether linalool accelerated the ubiquitination and degrada-
tion of HMGCR. Detergent-solubilized cell extracts were subjected
to immunoprecipitation with polyclonal antibodies against the
reductase, and the resulting immunoprecipitates were immuno-
blotted with an anti-ubiquitin antibody. In the anti-ubiquitin
immunoblots of reductase immunoprecipitates from cells treatedlls and mouse livers after treatment were prepared as described in Section 2. The
NA and protein expression. (B) Insig-1 protein expression. (C) Insig-dependent
of sterols (1 g/ml 25-hydroxycholesterol and 10 g/ml mevalonate) for 24 h at 37 C.
nd protein A/G Plus agarose beads. Aliquots of cell lysates and immunoprecipitates
onal antibody against ubiquitin (IgG-P4D1; 1:1000). Immunoreactive bands were
3294 S.-Y. Cho et al. / FEBS Letters 585 (2011) 3289–3296with 25-HC and mevalonate for 24 h, ubiquitinated reductase ap-
peared as a high-molecular-weight smear, which was not present
in immunoblots of control cells. In the presence of linalool, the cells
showed a marked increase in the amount of ubiquitinated reduc-
tase (Fig. 3C). These results suggested that linalool reduced the
expression of HMGCR via downregulation of SREBP-2 and also pro-
moted the Insig-dependent ubiquitination of endogenous HMGCR
protein.3.4. Binding of SREBP-2 to the HMGCR promoter is reduced with
linalool treatment
The HMGCR promoter has multiple transcription factor bind-
ing sites: a sterol regulatory element (SRE; 172 to 163) for
SREBP-2 and a cAMP responsive element (CRE; 110 to 103)
for CREB, which is activated by P300/CBP-associated factor (PCAF)
acetylation [18]. This acetylation on the CRE sequence has been
shown to induce SREBP-2 binding by stabilizing protein–DNA
complexes on the promoter [19]. To investigate the effects of lin-
alool treatment on transcription factor binding to the HMGCR
promoter, ChIP analysis was performed with anti-SREBP-2 and
anti-PCAF antibodies, followed by real-time PCR analysis using
bound and input DNA. In HepG2 cells, both linalool concentra-
tions reduced the binding of SREBP-2 to the HMGCR promoter
by up to 70% (P < 0.05; Fig. 4B). Similarly, PCAF binding to the
CRE was reduced by 57% and 88% at 0.1 and 0.5 mM linalool,
respectively (P < 0.01; Fig. 4B). These results were conﬁrmed by
quantitative PCR analysis, which showed similar trends (Fig. 4B).Fig. 4. ChIP analysis of SREBP-2 and PCAF binding to the HMGCR promoter in control and
methods. Antibodies against SREBP-2 and PCAF were used for ChIP, followed by real-tim
HMGCR promoter. (A) Immunoprecipitated DNA was ampliﬁed with SRE and CRE primer
Input: an aliquot of 10% total DNA input; SREBP-2: samples immunoprecipitated with
samples immunoprecipitated with rabbit IgG antibody as control for non-speciﬁc imm
induction was calculated as the ratio between the mean cycle threshold (Ct) value of the
with control; ⁄⁄P < 0.01 compared with control.4. Discussion
The results of the present study indicated that linalool treatment
of HFD-fed mice reduced the total plasma and LDL cholesterol con-
centrations with a concomitant reduction in hepatic lipid levels.
HDL cholesterol levels tended to increase, and this induction could
become signiﬁcant with an increased sample size. In a meta-analy-
sis, a 10 mg/dl reduction in plasma cholesterol levels decreased the
CHDmortality by up to 9% [2], which suggests that such a reduction
in total cholesterol is possible with linalool consumption from teas
and herbs. Therefore, this compound may have signiﬁcant implica-
tions for a reduced rate of CHD in the general population. This pos-
sibility should be conﬁrmed in future human studies.
Results showed dose-dependent cholesterol and TG reduction in
hepatocytes (Fig. 1B). We used two doses in the present animal
study, indicated as low (0.57 mg/mouse/d) and high concentrations
(120 mg/mouse/d). Our animal experiment showed that both low
and high concentrations of linalool showed similar hypocholestero-
lemic activities, i.e., a low concentration of linalool is sufﬁcient to
reduce plasma cholesterol levels in mice and non-toxic high con-
centration also showed similar effects. However, both tested con-
centrations may not have been optimum linalool concentrations
for hypocholesterolemic effects, and the results at least conﬁrmed
that these two concentrations were effective for reducing total
and LDL cholesterol levels in mice. Various concentrations should
be tested to determine the optimal dosage for future human trials.
Our ﬁndings indicated that the hypocholesterolemic effect of linal-
ool was achievedmainly by decreased expression of HMGCR, amar-
ker for hepatic cholesterol synthesis [20]. We showed that thelinalool-treated HepG2 cells. The detailed method is provided in the Supplementary
e PCR ampliﬁcation of the 180-bp region surrounding the SRE and CRE sites of the
s, and the products were resolved in 2% agarose gels stained with ethidium bromide.
SREBP-2 antibody; PCAF: samples immunoprecipitated with PCAF antibody; IgG:
unoprecipitation. (B) Quantiﬁcation of ChIP samples using real-time PCR. The fold
input or treated sample and that of the corresponding control. ⁄P < 0.05 compared
Fig. 5. Proposed mechanisms for the hypocholesterolemic actions of linalool. SSD, sterol sensing domain; SCAP, SREBP cleavage activating protein.
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duced reduction of SREBP-2 expression aswell as a linalool-induced
acceleration of ubiquitin-dependent HMGCR degradation. The pro-
posed multiple hypocholesterolemic mechanisms of linalool are
summarized in Fig. 5.
Several lines of evidence indicated that linalool reduced SREBP-2
expression: qPCR analysis demonstrated a decrease in SREBP-2
mRNA level; immunoblotting, immunohistochemistry, and ChIP
analyses revealed reduced SREBP-2 protein levels, especially in its
mature nuclear form; and nSREBP-2 decreased its binding to the
HMGCR promoter, SRE. The expression of the LDL receptor, a
well-known target gene for SREBP-2, was unaltered. The LDL recep-
tor is a well-known target gene for SREBP-2, and its expression is
often downregulated with the suppression of SREBP-2 activity in
both mice and humans. We do not have a clear explanation for
the lack of a change in LDL receptor expression. However, the LDL
receptor promoter is operated by multiple transcription factors
with both sterol-dependent and non-sterol-dependent mecha-
nisms [21]. Therefore, the possibility exists that the unaltered LDL
receptor expression is due to a combined effect of reduced SREBP-
2 and non-sterol-dependent mechanisms, which could compensate
for cellular cholesterol reduction by HMGCR downregulation.
The SREBP pathway is well understood [22]. The active form of
the SREBP transcription factor is released from the amino-terminal
domain of the SREBP precursor by proteolytic cleavage in the Golgi
apparatus. Two separate site-speciﬁc proteolytic cleavages cata-
lyzed by site-1 protease (S1P) and site-2 protease (S2P), respec-
tively, in the Golgi membrane are necessary for the release of the
transcriptionally active amino-terminal domain of the SREBP pre-
cursor. In addition, the regulated release of transcriptionally active
SREBP requires the cholesterol-sensing SREBP chaperone, SCAP,which forms a complex with the SREBP precursor via an interaction
between their respective carboxy-terminal domains [23]. The ac-
tive SREBP is translocated to the nucleus, where it binds to the
SRE sequence of target gene promoters to increase transcription
rates.
This mechanism is primarily regulated by cellular sterol concen-
trations. Sterol binding to SCAP under high-sterol conditions allows
the reversible binding of SCAP to Insig, another ERresident mem-
brane protein, to form an Insig:SCAP:SREBP triple complex in the
ER membrane [24]. Under low-sterol conditions, Insig is released
from the complex, and SCAP escorts SREBP from the ER to the Golgi
apparatus, where proteolytic cleavage by S1P and S2P release active
SREBP from the amino-terminal end of the precursor. After its
translocation to the nucleus, SREBP activates HMGCR transcription
[25]. In the present study, we showed that linalool administration
slightly attenuates nuclear translocation of SREBP-2 by altering
the expression of Insig-1. The expression of Insig-1, which enhances
ER retention of SREBP-2 [26], was signiﬁcantly upregulated with
linalool. The ratio of the nuclear-to-precursor form of SREBP-2
was somewhat reduced with linalool treatment, and the attenuated
nuclear translocation of SREBP-2 could, at least in part, contribute
to decreased HMGCR transcription. We also conﬁrmed that linalool
directly suppressed the binding of the SREBP-2 coactivator PCAF to
the CRE sequence of the HMGCR promoter, suggesting that the
reduction of SREBP-2 binding to the HMGCR promoter subse-
quently decreased the recruitment of PCAF.
HMGCR is also posttranscriptionally regulated by the ubiquitin–
proteasome system, which degrades ER membrane proteins
through ER-associated degradation [24,27]. The central event in
this process is sterol-stimulated binding of the reductase mem-
brane domain to Insig proteins, which are bound to the ubiquitin
3296 S.-Y. Cho et al. / FEBS Letters 585 (2011) 3289–3296ligase, gp78 [28]. The membrane-anchored gp78 mediates ubiqui-
tination of HMGCR, an obligate reaction for accelerated enzyme
degradation. Non-sterol, mevalonate-derived products cannot
stimulate ubiquitination or degradation of HMGCR in sterol-de-
prived cells, but can augment enzyme degradation in cells replete
with sterols [26,27]. Metabolic evidence suggests that several mol-
ecules, including intermediates in sterol biosynthesis, may regulate
this process. The 20-carbon isoprenoid geranylgeraniol, a choles-
terol biosynthesis intermediate, and lanosterol, a methylated ste-
rol, potently stimulate Insig-dependent ubiquitination and
degradation of HMGCR [28]. In addition, oxysterols derived from
the conversion of either endogenous or LDL-derived cholesterol
also stimulate the acceleration of reductase degradation [29]. Thus,
selective recognition of sterol ligands by HMGCR and SCAP appears
to contribute to the ability of Insig proteins to mediate the regula-
tion of both proteins through distinct mechanisms. In addition,
tocotrienols, naturally occurring forms of vitamin E, are direct,
posttranscriptional suppressors that presumably mimic non-sterol
isoprenoids in accelerating reductase degradation [24]. In the pres-
ent study, we showed that linalool mimics non-sterol isoprenoids
in promoting Insig-dependent ubiquitination and degradation of
HMGCR in addition to reducing SREBP-2 expression. We reasoned
that the upregulation of Insig-1 expression with linalool and the
two non-sterol isoprene units in the chemical structure of linalool
may be associated with the Insig-dependent ubiquitination of
HMGCR. Ubiquitin-dependent degradation of HMGCR was mark-
edly induced following linalool treatment. Linalool appears to be
less potent than 25-HC, mevalonate, and tocotrienol as high linal-
ool levels (100–500 lM) exerted similar effects to these com-
pounds. Thus, the non-sterol isoprene unit of linalool may exert
the effect, which is as effective as that of 25-HC, mevalonate, and
tocotrienol.
In conclusion, linalool is hypocholesterolemic with multiple
mechanisms of action: decreased mRNA and protein expression
of SREBP-2, attenuation of nuclear translocation of SREBP-2 with
altered expression of Insig-1, thereby suppressing HMGCR tran-
scription, and ﬁnally accelerating the Insig-1-dependent ubiquiti-
nation of HMGCR. This is one of few studies describing the
molecular mechanism of aromatic food compounds, given that
most previous phytochemical studies have investigated lipid-
soluble molecules. Our results indicated that food molecules with
a pleasant smell may have beneﬁcial metabolic effects with multi-
ple mechanisms of action.Conﬂict of interest statement
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